Effects of Endocrine Disruptors on the Gut Microbiota and Assessment of Their Impact on Colorectal Cancer Development (PERMICA)

Recruiting N/A Interventional Study
Colorectal Cancer (CRC) Endocrine Disruptors Microbiota Dysbiosis
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
200 (estimated)
Sponsor
Poitiers University Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Colorectal cancer is the third most common cancer worldwide, yet it was the second leading cause of cancer-related deaths in 2020. The average French population faces a colorectal cancer risk partly linked to lifestyle factors. The majority of colorectal cancer cases (approximately 85%) are not caused by hereditary mutations. Environmental factors, such as lifestyle or diet (notably through endocr…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Scheduled endoscopy during the inclusion visit or within 18 months following this consultation. * Signed consent from the patient after clear and fair information about the study is provided. * Patient is free of guardianship, curatorship, or dependency. * Patient is covered b…
Contacts

Violaine RANDRIAN, Doctor

00335 49 44 42 93

violaine.randrian@chu-poitiers.fr

CONTACT